Skip to content
Activity & longevityCohort study3 min read

More daily steps went with lower dementia risk in 78 430 UK adults; faster steps added more

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Association of Daily Step Count and Intensity With Incident Dementia in 78 430 Adults Living in the UK. · JAMA neurology · 2022 · Original paper ↗

Key takeaway

In 78 430 UK Biobank adults followed a median of 6.9 years, about 9826 steps a day was linked to lower dementia risk (HR 0.49), and about 3826 steps to a smaller reduction (HR 0.75), with faster stepping showing stronger links. This is an association from a single week of wrist-worn accelerometer data, and early dementia could itself reduce activity.

Study design

Cohort study

Reading basis

Published abstract

Reading focus

Association & confounding

The research question

Dementia-prevention guidelines may eventually be framed in steps, but how step count and walking pace relate to dementia was unknown. The authors examined the dose-response relation between daily steps, step intensity and new all-cause dementia in UK adults.

Who and how

Prospective population-based cohort study from the UK Biobank (February 2013 to December 2015), analyzed in May 2022. Of 103 684 eligible adults aged 40 to 79 years, 78 430 with valid wrist accelerometer data were included. Exposures were daily step count, incidental steps (less than 40 steps per minute), purposeful steps (40 steps per minute or more) and peak 30-minute cadence. Dementia, fatal and nonfatal, was identified through hospital and primary care records and death registers through October 2021, and spline Cox regressions assessed dose-response associations.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Of 78 430 adults (mean age 61.1 years, SD 7.9), 866 developed dementia over a median follow-up of 6.9 years (IQR 6.4-7.5).
  2. 2
    The link with daily steps was nonlinear. The optimal dose (where risk reduction was greatest) was 9826 steps (HR 0.49, 95% CI 0.39-0.62), and the minimal dose (half the maximum reduction) was 3826 steps (HR 0.75, 95% CI 0.67-0.83).
  3. 3
    Intensity mattered: the optimal dose was 3677 incidental steps (HR 0.58, 95% CI 0.44-0.72), 6315 purposeful steps (HR 0.43, 95% CI 0.32-0.58) and a peak 30-minute cadence of 112 steps per minute (HR 0.38, 95% CI 0.24-0.60).

Limits & uncertainty

  1. 1
    Reverse causation is possible: people in the early stages of dementia may walk less, and only 866 people developed dementia over about 7 years.
  2. 2
    Activity was measured by a wrist accelerometer over a limited period at baseline, not over the whole follow-up, and the sample was 96.7% White, so results may not generalize to other groups.
  3. 3
    The abstract reports no results by sex or other subgroups. This reading is based on the abstract only.

What to take from it

Walking more, and including some brisk walking, went with lower dementia risk, with a large share of the benefit appearing at a few thousand steps. This is not proof that reaching 10 000 steps prevents dementia, and no one needs to hit an exact number. If you worry about memory, talk with a clinician.

Reading your own data

A wrist step counter measures the same kind of data. Compare your own weeks with the same device and wear pattern, and look at both total steps and faster stretches (cadence), but note that step counts differ between brands.

How to read this evidence

Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Importance

Step-based recommendations may be appropriate for dementia-prevention guidelines. However, the association of step count and intensity with dementia incidence is unknown.

Objective

To examine the dose-response association between daily step count and intensity and incidence of all-cause dementia among adults in the UK.

Design, setting, and participants

UK Biobank prospective population-based cohort study (February 2013 to December 2015) with 6.9 years of follow-up (data analysis conducted May 2022). A total of 78 430 of 103 684 eligible adults aged 40 to 79 years with valid wrist accelerometer data were included. Registry-based dementia was ascertained through October 2021.

Exposures

Accelerometer-derived daily step count, incidental steps (less than 40 steps per minute), purposeful steps (40 steps per minute or more), and peak 30-minute cadence (ie, mean steps per minute recorded for the 30 highest, not necessarily consecutive, minutes in a day).

Main outcomes and measures

Incident dementia (fatal and nonfatal), obtained through linkage with inpatient hospitalization or primary care records or recorded as the underlying or contributory cause of death in death registers. Spline Cox regressions were used to assess dose-response associations.

Results

The study monitored 78 430 adults (mean [SD] age, 61.1 [7.9] years; 35 040 [44.7%] male and 43 390 [55.3%] female; 881 [1.1%] were Asian, 641 [0.8%] were Black, 427 [0.5%] were of mixed race, 75 852 [96.7%] were White, and 629 [0.8%] were of another, unspecified race) over a median (IQR) follow-up of 6.9 (6.4-7.5) years, 866 of whom developed dementia (mean [SD] age, 68.3 [5.6] years; 480 [55.4%] male and 386 [54.6%] female; 5 [0.6%] Asian, 6 [0.7%] Black, 4 [0.4%] mixed race, 821 [97.6%] White, and 6 [0.7%] other). Analyses revealed nonlinear associations between daily steps. The optimal dose (ie, exposure value at which the maximum risk reduction was observed) was 9826 steps (hazard ratio [HR], 0.49; 95% CI, 0.39-0.62) and the minimal dose (ie, exposure value at which the risk reduction was 50% of the observed maximum risk reduction) was 3826 steps (HR, 0.75; 95% CI, 0.67-0.83). The incidental cadence optimal dose was 3677 steps (HR, 0.58; 95% CI, 0.44-0.72); purposeful cadence optimal dose was 6315 steps (HR, 0.43; 95% CI, 0.32-0.58); and peak 30-minute cadence optimal dose was 112 steps per minute (HR, 0.38; 95% CI, 0.24-0.60).

Conclusions and relevance

In this cohort study, a higher number of steps was associated with lower risk of all-cause dementia. The findings suggest that a dose of just under 10 000 steps per day may be optimally associated with a lower risk of dementia. Steps performed at higher intensity resulted in stronger associations.

Sources & attribution

Association of Daily Step Count and Intensity With Incident Dementia in 78 430 Adults Living in the UK.

Del Pozo Cruz B, Ahmadi M, Naismith SL, Stamatakis E.

JAMA neurology · 2022-10-01

DOI: 10.1001/jamaneurol.2022.2672 ↗PubMed · 36066874 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Observational meta-analysis

7,000 steps a day linked to lower risk of death, heart disease and dementia than 2,000

Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.

The Lancet Public Health

In-depth explainersRead study →
·Cohort study

Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers

Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.

Nature Medicine

In-depth explainersRead study →
·Observational meta-analysis

Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)

Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.

The Lancet Public Health

In-depth explainersRead study →
·Observational meta-analysis

Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality

In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.

BMJ

In-depth explainersRead study →
Activity & longevity →